VIDEO: Immunotherapy sequencing in NSCLC
In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, highlighted updated data in squamous cell lung cancer and mesothelioma presented at the Chemotherapy Foundation Symposium.
Herbst, who also serves as ensign professor of medicine and professor of pharmacology, and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital, also mentioned a talk that focused on immunotherapy sequencing in non-small cell lung cancer.
Collapse
Healio Interview
Leal T. Small Cell Lung Cancer: How Will We Sequence Immunotherapy and Novel Agents. Presented at: Chemotherapy Foundation Symposium; Nov. 4-6, 2020.
Socinski MA. Squamous Cell Lung Cancer, Mesothelioma, and Thymoma: Management Updates. Presented at: Chemotherapy Foundation Symposium; Nov. 4-6, 2020.